No profile data available.
BGM Group Ltd. (BGM) is a healthcare company in the antibacterial pharmaceuticals industry, based in Chengdu, China.
It reported revenue of $25.10 million for fiscal year 2024, down 46.0% from fiscal year 2023, and net income of -$1.44 million. Its market capitalization was $143.56 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended September 30, 2024; market data as of October 9, 2026.
, through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments.
BGM Group reported $25.10 million in revenue for fiscal year 2024, down 46.0% from $46.47 million in fiscal year 2023.
$143.56 million as of October 9, 2026.
Listed companies of a similar size in the same industry (antibacterial pharmaceuticals) include Insmed Incorporated (INSM), Vaxcyte, Inc. (PCVX), AN2 Therapeutics, Inc. (ANTX), Armata Pharmaceuticals, Inc. (ARMP).